Search research articles
Contact Us
Filters
Showing results (141-150 of 227) with videos related to
Page
of 23
Sort By:
Hemasphere
|
March 2, 2023
Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial
Katja Weisel, Meletios A Dimopoulos, Jesús San-Miguel, et al.
Skeletal Radiology
|
June 28, 2024
Myosteatosis in multiple myeloma: a key determinant of survival beyond sarcopenia
Thierno D Diallo, Ariane Irma Luise Blessing, Gabriele Ihorst, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 26, 2018
APC/C<sup>Cdh1</sup> regulates the balance between maintenance and differentiation of hematopoietic stem and progenitor cells
Daniel Ewerth, Stefanie Kreutmair, Andrea Schmidts, et al.
Haematologica
|
May 17, 2020
Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial
Sandra Maria Dold, Mandy-Deborah Möller, Gabriele Ihorst, et al.
British Journal of Haematology
|
October 23, 2015
From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration
Joschka Lorenz, Johannes Waldschmidt, Dagmar Wider, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
February 17, 2020
Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: A mixed-methods contextual analysis as part of the SMILe study
Lynn Leppla, Juliane Mielke, Maria Kunze, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 14, 2017
Paving the Way for Dose Banding of Chemotherapy: An Analytical Approach
Heike Reinhardt, Rainer Trittler, Alison G Eggleton, et al.
American Journal of Hematology
|
September 10, 2025
European Myeloma Network Consensus Statement on Functional High-Risk Multiple Myeloma
Sueh-Li Lim, Monika Engelhardt, Evangelos Terpos, et al.
Nature Medicine
|
July 17, 2007
Essential role of stromally induced hedgehog signaling in B-cell malignancies
Christine Dierks, Jovana Grbic, Katja Zirlik, et al.
European Journal of Haematology
|
May 1, 2024
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial
Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 227) with videos related to
Sort By:
Page
of 23
Hemasphere
|
March 2, 2023
Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial
Katja Weisel, Meletios A Dimopoulos, Jesús San-Miguel, et al.
Skeletal Radiology
|
June 28, 2024
Myosteatosis in multiple myeloma: a key determinant of survival beyond sarcopenia
Thierno D Diallo, Ariane Irma Luise Blessing, Gabriele Ihorst, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 26, 2018
APC/C<sup>Cdh1</sup> regulates the balance between maintenance and differentiation of hematopoietic stem and progenitor cells
Daniel Ewerth, Stefanie Kreutmair, Andrea Schmidts, et al.
Haematologica
|
May 17, 2020
Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial
Sandra Maria Dold, Mandy-Deborah Möller, Gabriele Ihorst, et al.
British Journal of Haematology
|
October 23, 2015
From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration
Joschka Lorenz, Johannes Waldschmidt, Dagmar Wider, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
February 17, 2020
Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: A mixed-methods contextual analysis as part of the SMILe study
Lynn Leppla, Juliane Mielke, Maria Kunze, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 14, 2017
Paving the Way for Dose Banding of Chemotherapy: An Analytical Approach
Heike Reinhardt, Rainer Trittler, Alison G Eggleton, et al.
American Journal of Hematology
|
September 10, 2025
European Myeloma Network Consensus Statement on Functional High-Risk Multiple Myeloma
Sueh-Li Lim, Monika Engelhardt, Evangelos Terpos, et al.
Nature Medicine
|
July 17, 2007
Essential role of stromally induced hedgehog signaling in B-cell malignancies
Christine Dierks, Jovana Grbic, Katja Zirlik, et al.
European Journal of Haematology
|
May 1, 2024
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial
Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, et al.
Page
of 23